Patients on Therapy/Children on SPINRAZA

have been treated with
SPINRAZA worldwide1*

there’s someone from almost every
age group who has taken SPINRAZA1,2

have been treated with
SPINRAZA worldwide1*

*Based on commercial patients, early access patients, and clinical trial participants through May 2022.
Clinical studies of SPINRAZA included patients from 3 days to 16 years of age at first dose but did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients.
Based on commercial patients in the US (including Puerto Rico) through May 2022.

Some moments are ordinary. Others, memorable. Watch the real-life stories of patients on SPINRAZA

Some individuals featured may be participating in Biogen clinical trials.

Camden // age 4 // presymptomatic SMA

“We’re just so thankful and blessed where he’s at right now.”

Sofia // age 2.5 // early-onset SMA

“She has so much joy and so much love and so much drive.”

Ruby // age 6 // later-onset SMA

“We feel like we have this tool to fight back with.”

Ashley // age 7 // later-onset SMA

“The little gains mean so much.”

Carlee // age 11 // later-onset SMA

“This is hope for her future.”

Considering SPINRAZA for your patient? Find resources for insurance, financial assistance, and more